Gabelli & CO Investment Advisers, Inc. Horizon Therapeutics Public LTD CO Transaction History

Gabelli & CO Investment Advisers, Inc.

  • $535 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$98.98 - $115.74 $2.24 Million - $2.62 Million
22,600 Added 6.88%
351,075 $40.6 Million
Q2 2023

Aug 10, 2023
BUY
$96.34 - $112.38 $2.2 Million - $2.57 Million
22,875 Added 7.49%
328,475 $33.8 Million
Q1 2023

May 12, 2023
BUY
$107.32 - $113.5 $16.9 Million - $17.9 Million
157,900 Added 106.91%
305,600 $33.4 Million
Q4 2022

Feb 13, 2023
BUY
$62.39 - $113.8 $9.22 Million - $16.8 Million
147,700 New
147,700 $16.8 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Gabelli & CO Investment Advisers, Inc. Portfolio

Follow Gabelli & CO Investment Advisers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli & CO Investment Advisers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gabelli & CO Investment Advisers, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email